Goldman Sachs’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $14.2M | Buy |
|
|||||
|
2022
Q2 | $1.14M | Sell |
|
|||||
|
2022
Q1 | $2.49M | Buy |
|
|||||
|
2021
Q4 | $1.59M | Buy |
|
|||||
|
2021
Q3 | $2.45M | Sell |
|
|||||
|
2021
Q2 | $3.73M | Buy |
|
|||||
|
2021
Q1 | $3.92M | Sell |
|
|||||
|
2020
Q4 | $3.47M | Sell |
|
|||||
|
2020
Q3 | $14M | Buy |
|
|||||
|
2020
Q2 | $7.46M | Buy |
|
|||||
|
2020
Q1 | $2.58M | Buy |
|
|||||
|
2019
Q4 | $2.21M | Sell |
|
|||||
|
2019
Q3 | $8.63M | Buy |
|
|||||
|
2019
Q2 | $9.66M | Buy |
|
|||||
|
2019
Q1 | $8M | Buy |
|
|||||
|
2018
Q4 | $3.44M | Sell |
|
|||||
|
2018
Q3 | $6.58M | Buy |
|
|||||
|
2018
Q2 | $6.5M | Sell |
|
|||||
|
2018
Q1 | $9.08M | Buy |
|
|||||
|
2017
Q4 | $9.44M | Sell |
|
|||||
|
2017
Q3 | $8.13M | Sell |
|
|||||
|
2017
Q2 | $10.8M | Sell |
|
|||||
|
2017
Q1 | $10.1M | Buy |
|
|||||
|
2016
Q4 | $6.57M | Sell |
|
|||||
|
2016
Q3 | $9.73M | Sell |
|
|||||
|
2016
Q2 | $8.01M | Buy |
|
|||||
|
2016
Q1 | $5.12M | Buy |
|
|||||
|
2015
Q4 | $547K | Sell |
|
|||||
|
2015
Q3 | $479K | Sell |
|
|||||
|
2015
Q2 | $5.02M | Sell |
|
|||||
|
2015
Q1 | $9.96M | Buy |
|
|||||
|
2014
Q4 | $7.78M | Sell |
|
|||||
|
2014
Q3 | $10.1M | Buy |
|
|||||
|
2014
Q2 | $7.66M | Buy |
|